HealthDay News — TV characters are more likely to receive cardiopulmonary resuscitation (CPR) than people in real life, ...

Manufacturers to remove suicidal ideation warnings from Saxenda, Wegovy, and Zepbound labels following a large-scale FDA safety investigation.

An extension was required to provide time to review additional data requested by the FDA to clarify sparsentan’s clinical benefit.

Internal FDA reviews examined in the JAMA study show that the agency repeatedly confirmed that mifepristone is safe. One analysis found that among 1.88 million patients who had used the drug in the US ...

Zycubo is a copper replacement therapy administered via subcutaneous injection to bypass impaired GI absorption in patients with Menkes disease.

Higher rates of glaucoma therapy seen at increasing IOP levels, with cutoff of 22 mm Hg influencing clinician decision-making ...

Cessation of weight management medications (WMMs) is followed by rapid weight regain and reversal of beneficial effects on cardiometabolic markers, according to a review published online January 7 in ...

Tabelecleucel, an allogeneic, EBV-specific T-cell immunotherapy, works by targeting and eliminating EBV-infected cells.

Zanidatamab + chemotherapy, with or without tislelizumab, may increase survival in metastatic or locally advanced gastroesophageal adenocarcinoma ...

The wearable device delivers electrical impulses through a headset that can be administered by the patient at home under physician oversight.

Risks for influenza- and pertussis-related hospitalization, ED visits lower in infants younger than 6 months among those born to mothers who received vaccines.

Mass spectrometry testing should be considered for specific patients or when results could affect downstream care.